@article{Leavy_O-2024_188032,
title = {1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study},
author = {Leavy, O. and Russell, R. and Harrison, E. and Lone, N. and Kerr, S. and Docherty, A. and Sheikh, A. and Richardson, M. and Elneima, O. and Greening, N. and Harris, V. and Houchen-Wolloff, L. and McAuley, H. and Saunders, R. and Sereno, M. and Shikotra, A. and Singapuri, A. and Aul, R. and Beirne, P. and Bolton, C. and Brown, J. and Choudhury, G. and Diar Bakerly, N. and Easom, N. and Echevarria, C. and Fuld, J. and Hart, N. and Hurst, J. and Jones, M. and Parekh, D. and Pfeffer, P. and Rahman, N. and Rowland-Jones, S. and Shah, A. and Wootton, D. and Jolley, C. and Thompson, A. and Chalder, T. and Davies, M. and De Soyza, A. and Geddes, J. and Greenhalf, W. and Heller, S. and Howard, L. and Jacob, J. and Jenkins, R. and Lord, J. and Man, W. and McCann, G. and Neubauer, S. and Openshaw, P. and Porter, J. and Rowland, M. and Scott, J. and Semple, M. and Singh, S. and Thomas, D. and Toshner, M. and Lewis, K. and Heaney, L. and Briggs, A. and Zheng, B. and Thorpe, M. and Quint, J. and Chalmers, J. and Ho, L. and Horsley, A. and Marks, M. and Poinasamy, K. and Raman, B. and Wain, L. and Brightling, C. and Evans, R.},
month = {aug},
year = {2024},
abstract = {BACKGROUND: In patients with coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, dexamethasone reduces acute severity and improves survival, but longer-term effects are unknown. We hypothesised that systemic corticosteroid administration during acute COVID-19 would be associated with improved health-related quality of life (HRQoL) 1 year after discharge.},
journal = {ERJ Open Research},
publisher = {ERS Publications},
url = {https://doi.org/10.1183/23120541.00474-2024},
}
